Virtus Investment Advisers’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.6K | Sell |
2,832
-438
| -13% | -$14.5K | 0.03% | 360 |
|
|
2025
Q1 | $131K | Buy |
+3,270
| New | +$131K | 0.04% | 374 |
|
|
2024
Q1 | – | Sell |
-4,718
| Closed | -$394K | – | 355 |
|
|
2023
Q4 | $394K | Sell |
4,718
-3,946
| -46% | -$329K | 0.3% | 107 |
|
|
2023
Q3 | $255K | Buy |
8,664
+720
| +9% | +$21.2K | 0.17% | 146 |
|
|
2023
Q2 | $259K | Sell |
7,944
-4,870
| -38% | -$159K | 0.18% | 157 |
|
|
2023
Q1 | $451K | Sell |
12,814
-1,767
| -12% | -$62.2K | 0.32% | 101 |
|
|
2022
Q4 | $668K | Hold |
14,581
| – | – | 0.45% | 60 |
|
|
2022
Q3 | $706K | Buy |
+14,581
| New | +$706K | 0.32% | 50 |
|